PCP Withdrawal: Symptoms, Depression, Craving and Treatment

PCP withdrawal can include intense craving, depression, anxiety, changes in sleep and appetite, headache, sweating and other physical or psychological symptoms after repeated phencyclidine use stops. Human research on PCP withdrawal is limited, so there is no reliable day-by-day timeline that applies to everyone. The safest interpretation depends on the person’s recent PCP exposure, mental state, medical condition and use of alcohol, benzodiazepines, opioids, stimulants or other drugs.

Repeated PCP use can produce tolerance and a substance use disorder. Older NIDA clinical summaries describe a PCP withdrawal syndrome that includes craving, headache and sweating. SAMHSA detoxification guidance also describes depression, drug craving, increased appetite and excessive sleepiness after chronic PCP use stops. Some psychiatric and cognitive problems associated with long-term PCP use can last far longer than the initial withdrawal period, including depression, anxiety, memory problems and psychotic symptoms.

A person who has seizures, severe agitation, hallucinations with unsafe behavior, very high body temperature, major confusion, abnormal breathing or suicidal intent needs emergency medical evaluation. Those findings can reflect PCP toxicity, another drug, a medical complication or a severe psychiatric condition, and they should not be managed as an expected home withdrawal experience.

PCP Withdrawal at a Glance

What PCP Withdrawal Can Feel Like

PCP affects glutamate signaling by blocking NMDA receptors and also influences dopamine activity. With repeated exposure, the brain and behavior can adapt to the drug. NIDA has reported that repeated PCP use can lead to tolerance and a substance use disorder with withdrawal symptoms when use stops. The best-documented withdrawal complaints include craving, headache and sweating, while SAMHSA detoxification guidance adds depression, increased appetite and hypersomnolence, meaning excessive sleepiness.

MedlinePlus describes additional reactions after stopping PCP that can include anxiety, agitation, confusion, irritability and hallucinations. It also lists physical reactions such as muscle twitching, increased body temperature and seizures. These severe findings require careful interpretation because PCP intoxication itself can also produce agitation, hyperthermia, muscle injury and seizures. A clinician evaluating someone after PCP use needs to determine whether the person is withdrawing, still intoxicated, experiencing a complication of intoxication, reacting to another substance or developing an independent psychiatric or medical problem.

Craving can be clinically significant even when outward physical symptoms look mild. A person may feel physically improved and still have a strong drive to use PCP again. Depression, anxiety and disturbed sleep can make that urge harder to manage, especially when the person returns quickly to the same environment, social contacts or drug access associated with prior use.

PCP Withdrawal Timeline: What the Evidence Actually Supports

A precise PCP withdrawal clock is poorly established in human research. Published sources do not support a universal schedule such as “symptoms peak on day three and end on day seven.” PCP also has a complicated clinical course because acute intoxication can last for hours, severe psychiatric symptoms can persist after the obvious high has ended, and repeated use can leave longer-lasting cognitive or mood problems.

NIDA has reported that depression, anxiety, memory loss, speech difficulties, suicidal thoughts and social withdrawal associated with long-term PCP use may persist for a year or longer after chronic use stops. That statement should be interpreted as evidence of possible long-term consequences after chronic exposure, not as proof that every person experiences a year-long PCP withdrawal syndrome.

The practical marker is clinical recovery, not a countdown. Improving sleep, mood, concentration and craving are useful signs, while worsening depression, psychosis, agitation or medical symptoms call for reassessment.

PCP Withdrawal, the End of Intoxication and Persistent PCP Effects

PCP can produce dissociation, confusion, abnormal eye movements, hypertension, agitation, impaired coordination, hallucinations and psychosis during intoxication. High exposure can also cause seizures, hyperthermia, coma, muscle breakdown and serious injury. These acute effects can overlap with symptoms that appear during the period after use stops.

A person who remains paranoid or disorganized after the expected intoxication period may have prolonged PCP-related psychosis, severe sleep deprivation, another psychiatric disorder or exposure to additional drugs. Calling every post-PCP symptom “withdrawal” can hide those possibilities. Persistent psychotic symptoms deserve evaluation even when the person has stopped using and a urine drug screen is moving toward negative.

The timing of a drug test also cannot define withdrawal. PCP can remain detectable after obvious intoxication has resolved, especially after repeated use. PCP drug testing answers whether exposure may still be detectable; it cannot establish whether a person is currently impaired or whether a particular symptom is withdrawal.

Depression, Craving, Sleep and Appetite Changes

Depression and craving deserve particular attention during early PCP recovery because they can drive rapid return to use. SAMHSA detoxification guidance specifically identifies depression and drug craving among PCP withdrawal symptoms. Low mood can also reflect the psychological consequences of repeated intoxication, disrupted relationships, legal problems, injuries, sleep loss or a co-occurring depressive disorder.

Sleep can shift in either direction during the transition away from repeated drug use. SAMHSA describes hypersomnolence after PCP cessation, while real-world patients may also arrive with irregular sleep from recent intoxication, agitation or polysubstance use. Increased appetite can occur as the person returns to more regular sleep and eating patterns after repeated PCP exposure. Nutrition and hydration may need attention when prolonged intoxication, poor intake or physical exertion preceded treatment.

Craving often outlasts the period of obvious physical discomfort. Environmental cues can be powerful: people, places, cannabis or cigarettes associated with PCP use, and memories of the dissociative state can trigger urges even after sleep and appetite have improved. Treatment therefore needs to continue after acute stabilization. PCP addiction treatment focuses on the longer pattern of compulsive use, triggers, psychiatric symptoms and relapse risk.

Anxiety, Agitation, Hallucinations and Seizures Need Careful Interpretation

MedlinePlus includes anxiety, agitation, confusion, hallucinations and seizures among possible reactions when a person stops PCP. Severe versions of these symptoms should be treated as clinical warning signs because the same findings can occur during PCP intoxication, after a very large exposure, with another drug or during withdrawal from alcohol or sedatives.

A seizure after recent PCP use is an emergency. It should never be assumed to be a predictable stage of withdrawal. PCP toxicity can cause seizures, severe muscle contractions and hyperthermia, and seizure activity can contribute to muscle breakdown, kidney injury and other complications. Agitation combined with high temperature, marked confusion or extreme physical activity also requires urgent evaluation.

Hallucinations or delusions may persist after PCP intoxication. NIDA notes that PCP can cause psychosis lasting days to weeks in some cases. A person who cannot distinguish what is real, becomes threatening or frightened enough to act unsafely, cannot care for basic needs or develops suicidal thinking needs psychiatric and medical assessment. PCP psychosis requires a different clinical response from uncomplicated craving or fatigue.

Why Repeated PCP Use Can Produce Dependence and Difficult Recovery

PCP is a dissociative NMDA receptor antagonist. Glutamate signaling through NMDA receptors is involved in learning, memory, emotion and pain perception. PCP also changes dopamine activity, which contributes to its reinforcing and behavioral effects. Repeated exposure can produce tolerance, meaning the person needs greater exposure to achieve effects that previously occurred with less drug.

Tolerance and craving can support a compulsive cycle even when withdrawal lacks the highly standardized pattern seen with some other drugs. The person may use PCP again to escape depression, anxiety, craving or the emotional aftermath of stopping. Repeated intoxication then brings back the risks of psychosis, injury, impaired judgment, high blood pressure, overheating and unpredictable behavior.

Cognitive recovery may also complicate treatment. NIDA has associated chronic PCP use with memory and speech problems, and experimental research has long examined cognitive impairment after repeated PCP exposure. Someone who is struggling with attention or memory may have difficulty following appointments, remembering coping plans or returning immediately to work or school. Treatment planning should account for actual functioning instead of assuming that the end of intoxication equals complete neurologic recovery.

How PCP Withdrawal Differs From Alcohol, Benzodiazepine and Opioid Withdrawal

Different drugs produce different withdrawal syndromes. Alcohol and benzodiazepines have established withdrawal patterns in which seizures and delirium can become life-threatening. Opioids produce a characteristic syndrome that often includes muscle aches, gastrointestinal symptoms, runny nose, yawning and marked autonomic discomfort. PCP discontinuation is documented more through craving, mood changes, sleep and appetite changes, headache, sweating and psychiatric symptoms, with a much less standardized human timeline.

This comparison becomes especially important when several substances are involved. Someone who reports “PCP detox” may actually have simultaneous alcohol, benzodiazepine, opioid or stimulant withdrawal that changes the medical risk completely.

Polysubstance Use Can Change the Withdrawal Risk

A complete substance history is essential after repeated PCP use. SAMHSA emergency-department data have shown that PCP-related visits frequently involve additional substances. Alcohol, cannabis, cocaine, opioids, benzodiazepines and other drugs can add intoxication effects, create separate withdrawal syndromes or make psychiatric symptoms harder to interpret.

Daily alcohol or benzodiazepine use is particularly important because stopping those substances can produce dangerous withdrawal even if PCP itself is the drug named in the referral. Opioid dependence changes the plan because opioid withdrawal and overdose risk require their own assessment. Stimulant cessation can add exhaustion, depression, sleep changes and craving. Cannabis withdrawal can contribute irritability and sleep disturbance.

Illicit drug identity is another source of uncertainty. A product sold as PCP, “wet” or “fry” may contain additional substances or may not contain what the person expected. Clinical care should use the reported drug history as useful information while also responding to the actual symptoms, vital signs, toxicology findings and collateral history.

Does PCP Withdrawal Require Medical Detox?

Some people stopping PCP can enter addiction treatment without a traditional medication-based detox admission. Others need monitored stabilization because the main risk is psychiatric or medical: persistent psychosis, suicidal thinking, severe depression, agitation, recent high-dose intoxication, trauma, dehydration, muscle injury or polysubstance withdrawal.

Assessment should establish when PCP was last used, how frequently it has been used, whether intoxication symptoms are still present and whether the person has been using alcohol, benzodiazepines, opioids or stimulants. Clinicians also need to assess sleep, hydration, injuries, body temperature, mental status and the person’s ability to remain safe.

Medical detox is best understood as evaluation and stabilization when intoxication or withdrawal creates clinical risk. For PCP, that can mean observation, psychiatric assessment, treatment of complications and a safe transition into continuing addiction care. A person with severe medical toxicity may need an emergency department or hospital instead of a freestanding detox program.

How PCP Withdrawal and Early Recovery Are Treated

There is no universal PCP-specific replacement medication comparable with methadone or buprenorphine for opioid use disorder. Treatment is based on the symptoms and the broader substance use disorder. MedlinePlus describes counseling and behavior-change treatment as part of PCP addiction care and notes that medicines may be used to treat withdrawal symptoms when clinically necessary.

During stabilization, care can include a low-stimulation environment, sleep, fluids and nutrition when needed, psychiatric observation and treatment of specific medical complications. Acute PCP intoxication with severe agitation or seizures is managed as a toxicologic emergency; clinical toxicology references describe benzodiazepines as first-line medication in that setting. Those medications are administered according to the patient’s medical condition and should not be converted into a home PCP-detox regimen.

Once the person is medically and psychiatrically stable, treatment shifts toward preventing return to PCP use. Counseling can address triggers, drug-using social networks, trauma, mood symptoms and the situations in which PCP is used. Co-occurring psychosis, depression, anxiety or other psychiatric illness may require dual-diagnosis treatment. A residential treatment program may fit when psychiatric instability, repeated relapse, polysubstance use or the home environment makes lower-intensity care unsafe or ineffective.

What Recovery Looks Like After the Acute Withdrawal Period

Early improvement may show up as more regular sleep, better appetite, less agitation and fewer immediate cravings. Longer recovery requires more than symptom relief. The person needs a plan for repeated PCP use itself, including access to the drug, people associated with use, psychiatric symptoms, legal or relationship consequences and other substances that may trigger return to use.

Persistent depression, anxiety, memory problems or speech difficulties deserve follow-up. NIDA has documented long-lasting psychiatric and cognitive consequences after chronic PCP exposure. These problems can interfere with work, school and treatment participation even after the person is no longer intoxicated. Cognitive complaints may also have other causes, including sleep deprivation, head injury, other drugs or an independent psychiatric condition.

Relapse risk can remain high after the body feels better because craving is partly learned and cue-driven. Direct transition from stabilization into ongoing treatment can reduce the gap in which the person returns to the same environment without support. Continued care may include outpatient counseling, residential care, psychiatric treatment, recovery housing or another level matched to the person’s current needs.

When to Seek Emergency Care After PCP Use Stops

Emergency evaluation is appropriate for a seizure, severe agitation, uncontrolled violent behavior, very high body temperature, collapse, abnormal breathing, inability to stay awake, major confusion, serious injury or signs of muscle breakdown such as severe muscle pain with dark urine. These findings can occur with serious PCP toxicity and can also reflect another medical emergency.

Hallucinations, delusions or paranoia become urgent when the person cannot maintain safety, is acting on frightening beliefs or cannot care for basic needs. Suicidal intent, a suicide attempt or behavior suggesting imminent self-harm also requires immediate emergency help. Chronic PCP use has been associated with depression and suicidal thoughts, so severe mood symptoms should be taken seriously during early recovery.

If another substance may be involved, tell emergency clinicians what was used or believed to be used, when it was taken and whether alcohol, sedatives, opioids, stimulants or prescription medications were also involved. Exact street-drug identity may be uncertain, and treatment can begin from the clinical findings while toxicology information is still being clarified.

Frequently Asked Questions About PCP Withdrawal

Does PCP cause withdrawal?

Yes. Federal health sources describe withdrawal after repeated PCP use. Reported symptoms include craving, depression, headache, sweating, appetite changes and increased sleepiness, with anxiety, agitation and other psychiatric or physical reactions also described.

How long does PCP withdrawal last?

There is no well-established human timeline that reliably predicts an exact onset, peak and end date. Craving, mood and sleep symptoms may improve as the person stabilizes, while psychiatric and cognitive effects after chronic use can persist much longer and require follow-up.

Can PCP withdrawal cause depression?

Depression is a documented concern after repeated PCP use stops. Severe, persistent or suicidal depression needs clinical evaluation because the cause can include PCP-related effects, another substance, life circumstances or an independent mood disorder.

Can PCP withdrawal cause seizures?

MedlinePlus lists seizures among possible reactions after stopping PCP, and seizures are also a recognized complication of PCP toxicity. A seizure after recent PCP use should be treated as an emergency because the cause cannot be safely determined at home.

Is there a medication for PCP withdrawal?

There is no established medication that directly substitutes for PCP or a universal PCP-specific withdrawal protocol. Clinicians can treat particular medical or psychiatric symptoms and then address the PCP use disorder with continuing addiction treatment.

Does everyone withdrawing from PCP need inpatient detox?

No. The required level of care depends on intoxication, psychiatric stability, medical complications, polysubstance use, suicide risk and the recovery environment. Severe psychosis, seizures, hyperthermia or other acute complications need emergency or hospital-level assessment.

Can PCP psychosis continue after the drug wears off?

Yes. NIDA reports that PCP can cause psychosis lasting days to weeks in some cases. Persistent hallucinations, paranoia or delusional thinking need psychiatric assessment even when the person has stopped using PCP.

Sources

• National Institute on Drug Abuse: Psychedelic and Dissociative Drugs: current NIH overview of PCP as a dissociative NMDA receptor antagonist, PCP use disorder and persistent psychiatric risks.
• National Institute on Drug Abuse: Hallucinogens and Dissociative Drugs Research Report: federal summary describing tolerance, PCP withdrawal symptoms and long-term effects after chronic use.
• SAMHSA TIP 45 Quick Guide: Detoxification and Substance Abuse Treatment: clinical detoxification guidance listing depression, drug craving, increased appetite and hypersomnolence with PCP withdrawal.
• MedlinePlus: Substance Use – Phencyclidine (PCP): consumer medical guidance on PCP dependence, withdrawal reactions and treatment.
• NCBI Bookshelf: Phencyclidine Toxicity: clinical toxicology review covering PCP intoxication, seizures, hyperthermia, rhabdomyolysis, psychosis and emergency management.
• PubMed: Phencyclidine Abuse, Dependence, Intoxication, and Psychosis: clinical review of PCP dependence, intoxication and psychiatric complications.